Search Results - "Kantarci, Kejal"

Proton MRS in mild cognitive impairment by Kantarci, Kejal

“…Mild cognitive impairment (MCI) is a clinical syndrome operationalized for early diagnosis and treatment of Alzheimer's disease (AD). Many individuals with MCI…”
Get full text

Understanding Proton Magnetic Resonance Spectroscopy Neurochemical Changes Using Alzheimer's Disease Biofluid, PET, Postmortem Pathology Biomarkers, and APOE Genotype by Kara, Firat, Kantarci, Kejal

“…In vivo proton ( H) magnetic resonance spectroscopy (MRS) is a powerful non-invasive method that can measure Alzheimer's disease (AD)-related neuropathological…”
Get full text

Understanding the impact of sex and gender in Alzheimer's disease: A call to action by Nebel, Rebecca A., Aggarwal, Neelum T., Barnes, Lisa L., Gallagher, Aimee, Goldstein, Jill M., Kantarci, Kejal, Mallampalli, Monica P., Mormino, Elizabeth C., Scott, Laura, Yu, Wai Haung, Maki, Pauline M., Mielke, Michelle M.

“…Precision medicine methodologies and approaches have advanced our understanding of the clinical presentation, development, progression, and management of…”
Get full text

Identification of Anonymous MRI Research Participants with Face-Recognition Software by Schwarz, Christopher G, Kremers, Walter K, Therneau, Terry M, Sharp, Richard R, Gunter, Jeffrey L, Vemuri, Prashanthi, Arani, Arvin, Spychalla, Anthony J, Kantarci, Kejal, Knopman, David S, Petersen, Ronald C, Jack, Clifford R

“…With the use of publicly available software, reconstructed facial images from deidentified cranial MRI scans were matched to photographs of individual study…”
Get full text

Preeclampsia and cognitive impairment later in life by Fields, Julie A., PhD, Garovic, Vesna D., MD, Mielke, Michelle M., PhD, Kantarci, Kejal, MD, Jayachandran, Muthuvel, PhD, White, Wendy M., MD, Butts, Alissa M., PhD, Graff-Radford, Jonathan, MD, Lahr, Brian D., MS, Bailey, Kent R., PhD, Miller, Virginia M., PhD

“…Background Hypertension is a risk factor for cerebrovascular disease and cognitive impairment. Women with hypertensive episodes during pregnancy report…”
Get full text

Imaging Biomarkers for Neurodegeneration in Presymptomatic Familial Frontotemporal Lobar Degeneration by Chen, Qin, Kantarci, Kejal

“…Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disorder characterized by behavioral changes, language abnormality, as well as executive…”
Get full text

Defining imaging biomarker cut points for brain aging and Alzheimer's disease by Jack, Clifford R, Wiste, Heather J, Weigand, Stephen D, Therneau, Terry M, Lowe, Val J, Knopman, David S, Gunter, Jeffrey L, Senjem, Matthew L, Jones, David T, Kantarci, Kejal, Machulda, Mary M, Mielke, Michelle M, Roberts, Rosebud O, Vemuri, Prashanthi, Reyes, Denise A, Petersen, Ronald C

“…Abstract Introduction Our goal was to develop cut points for amyloid positron emission tomography (PET), tau PET, flouro-deoxyglucose (FDG) PET, and MRI…”
Get full text

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease by Jack Jr, Clifford R., Knopman, David S., Weigand, Stephen D., Wiste, Heather J., Vemuri, Prashanthi, Lowe, Val, Kantarci, Kejal, Gunter, Jeffrey L., Senjem, Matthew L., Ivnik, Robert J., Roberts, Rosebud O., Rocca, Walter A., Boeve, Bradley F., Petersen, Ronald C.

“…Objective: A workgroup commissioned by the Alzheimer's Association (AA) and the National Institute on Aging (NIA) recently published research criteria for…”
Get full text

Predicting future rates of tau accumulation on PET by Jack, Clifford R, Wiste, Heather J, Weigand, Stephen D, Therneau, Terry M, Lowe, Val J, Knopman, David S, Botha, Hugo, Graff-Radford, Jonathan, Jones, David T, Ferman, Tanis J, Boeve, Bradley F, Kantarci, Kejal, Vemuri, Prashanthi, Mielke, Michelle M, Whitwell, Jennifer, Josephs, Keith, Schwarz, Christopher G, Senjem, Matthew L, Gunter, Jeffrey L, Petersen, Ronald C

“…Clinical trials with anti-tau drugs will need to target individuals at risk of accumulating tau. Our objective was to identify variables available in a…”
Get full text

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly by Vemuri, Prashanthi, Lesnick, Timothy G, Przybelski, Scott A, Knopman, David S, Preboske, Greg M, Kantarci, Kejal, Raman, Mekala R, Machulda, Mary M, Mielke, Michelle M, Lowe, Val J, Senjem, Matthew L, Gunter, Jeffrey L, Rocca, Walter A, Roberts, Rosebud O, Petersen, Ronald C, Jack, Jr, Clifford R

“…Our primary objective was to investigate a biomarker driven model for the interrelationships between vascular disease pathology, amyloid pathology, and…”
Get full text

Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers by Cogswell, Petrice M., Wiste, Heather J., Senjem, Matthew L., Gunter, Jeffrey L., Weigand, Stephen D., Schwarz, Christopher G., Arani, Arvin, Therneau, Terry M., Lowe, Val J., Knopman, David S., Botha, Hugo, Graff-Radford, Jonathan, Jones, David T., Kantarci, Kejal, Vemuri, Prashanthi, Boeve, Bradley F, Mielke, Michelle M., Petersen, Ronald C., Jack, Clifford R.

“…Altered iron metabolism has been hypothesized to be associated with Alzheimer's disease pathology, and prior work has shown associations between iron load and…”
Get full text

Changing the face of neuroimaging research: Comparing a new MRI de-facing technique with popular alternatives by Schwarz, Christopher G., Kremers, Walter K., Wiste, Heather J., Gunter, Jeffrey L., Vemuri, Prashanthi, Spychalla, Anthony J., Kantarci, Kejal, Schultz, Aaron P., Sperling, Reisa A., Knopman, David S., Petersen, Ronald C., Jack, Clifford R.

“…Recent advances in automated face recognition algorithms have increased the risk that de-identified research MRI scans may be re-identifiable by matching them…”
Get full text

Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART) by Josephs, Keith A., Murray, Melissa E., Tosakulwong, Nirubol, Whitwell, Jennifer L., Knopman, David S., Machulda, Mary M., Weigand, Stephen D., Boeve, Bradley F., Kantarci, Kejal, Petrucelli, Leonard, Lowe, Val J., Jack, Clifford R., Petersen, Ronald C., Parisi, Joseph E., Dickson, Dennis W.

“…We investigate whether there is any association between the Braak neurofibrillary tangle (NFT) stage and clinical and MRI features in definite primary…”
Get full text

White Matter Integrity on DTI and the Pathologic Staging of Alzheimer’s Disease by Kantarci, Kejal, MD, MS, Murray, Melissa E., PhD, Schwarz, Christopher G., PhD, Reid, Robert, PhD, Przybelski, Scott A, Lesnick, Timothy, MS, Zuk, Samantha M, Raman, Mekala R., PhD, Senjem, Matthew L., MS, Gunter, Jeffrey L., PhD, Boeve, Bradley F., MD, Knopman, David S., MD, Parisi, Joseph E., MD, Petersen, Ronald C., MD, PhD, Jack, Clifford R., MD, Dickson, Dennis, MD

“…Abstract Pattern of diffusion tensor MRI (DTI) alterations were investigated in pathologically-staged Alzheimer’s disease (AD) patients (n=46). Patients with…”
Get full text

Non-stationarity in the "resting brain's" modular architecture by Jones, David T, Vemuri, Prashanthi, Murphy, Matthew C, Gunter, Jeffrey L, Senjem, Matthew L, Machulda, Mary M, Przybelski, Scott A, Gregg, Brian E, Kantarci, Kejal, Knopman, David S, Boeve, Bradley F, Petersen, Ronald C, Jack, Jr, Clifford R

“…Task-free functional magnetic resonance imaging (TF-fMRI) has great potential for advancing the understanding and treatment of neurologic illness. However, as…”
Get full text

Magnetic Resonance Spectroscopy in Common Dementias by Kantarci, Kejal, MD, MS

“…Neurodegenerative dementias are characterized by elevated myoinositol and decreased N -acetylaspartate (NAA) levels. The increase in myoinositol seems to…”
Get full text

A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity by Schwarz, Christopher G, Gunter, Jeffrey L, Wiste, Heather J, Przybelski, Scott A, Weigand, Stephen D, Ward, Chadwick P, Senjem, Matthew L, Vemuri, Prashanthi, Murray, Melissa E, Dickson, Dennis W, Parisi, Joseph E, Kantarci, Kejal, Weiner, Michael W, Petersen, Ronald C, Jack, Jr, Clifford R

“…Alzheimer's disease (AD) researchers commonly use MRI as a quantitative measure of disease severity. Historically, hippocampal volume has been favored…”
Get full text

Cross–scanner harmonization methods for structural MRI may need further work: A comparison study by Gebre, Robel K., Senjem, Matthew L., Raghavan, Sheelakumari, Schwarz, Christopher G., Gunter, Jeffery L., Hofrenning, Ekaterina I., Reid, Robert I., Kantarci, Kejal, Graff-Radford, Jonathan, Knopman, David S., Petersen, Ronald C., Jack, Clifford R., Vemuri, Prashanthi

“…•Combining data from multicenter studies can result in data heterogeneity.•Different harmonization methods are used to solve this problem.•We compared the…”
Get full text

The Role of Diffusion Tensor Imaging in Detecting Microstructural Changes in Prodromal Alzheimer's Disease by Zhang, Bing, Xu, Yun, Zhu, Bin, Kantarci, Kejal

“…Summary The MRI technique diffusion tensor imaging (DTI) is reviewed along with microstructural changes associated with prodromal Alzheimer's disease (AD) as a…”
Get full text

Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation by Schwarz, Christopher G., Therneau, Terry M., Weigand, Stephen D., Gunter, Jeffrey L., Lowe, Val J., Przybelski, Scott A., Senjem, Matthew L., Botha, Hugo, Vemuri, Prashanthi, Kantarci, Kejal, Boeve, Bradley F., Whitwell, Jennifer L., Josephs, Keith A., Petersen, Ronald C., Knopman, David S., Jack, Clifford R.

“…Since tau PET tracers were introduced, investigators have quantified them using a wide variety of automated methods. As longitudinal cohort studies acquire…”
Get full text